All I know is is that I added to my PTN holdings @ .49 They will announce top-line phase III results in September and I strongly suspect there will be a partner announcement prior-
From CC: "In light of the above events and the significant progress of the bremelanotide Phase III clinical trials, we have received increased interest from potential licensing partners...The data is coming out late third quarter, in the September timeframe. So we are doing what we need to do from the Phase III trials. Dotting the I's, crossing the T's --"